Cefixime: Difference between revisions
Ahmed Zaghw (talk | contribs) |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 9: | Line 9: | ||
Antibacterial | Antibacterial | ||
==US Brand Names== | ==US Brand Names== | ||
Suprax<sup>®</sup> | '''Suprax<sup>®</sup>''' | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
Revision as of 21:05, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Overview
Cefixime (Suprax in the USA )is a cephalosporin antibiotic used to treat bacterial infections. The bactericidal action of cephalosporin due to the inhibition of cell wall synthesis. It binds to one of the penicillin binding proteins (PBPs) which inhibits the final transpeptidation step of the peptidoglycan synthesis in the bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death.
Category
Antibacterial
US Brand Names
Suprax®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages